Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Multiple Sclerosis

  Free Subscription


26.03.2018

1 BMC Neurol
1 Can J Neurol Sci
2 Curr Treat Options Neurol
1 J Neuroimmunol
3 J Neurol
1 J Neurol Neurosurg Psychiatry
1 Lancet
2 Lancet Neurol
1 Mult Scler
1 Neurology
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    BMC Neurol

  1. CHU R, Hurwitz S, Tauhid S, Bakshi R, et al
    Automated segmentation of cerebral deep gray matter from MRI scans: effect of field strength on sensitivity and reliability.
    BMC Neurol. 2017;17:172.
    PubMed     Text format     Abstract available


    Can J Neurol Sci

  2. AL-SAKRAN LH, Marrie RA, Blackburn DF, Knox KB, et al
    Establishing the Incidence and Prevalence of Multiple Sclerosis in Saskatchewan.
    Can J Neurol Sci. 2018 Mar 20:1-9. doi: 10.1017/cjn.2017.
    PubMed     Text format     Abstract available


    Curr Treat Options Neurol

  3. LAMBE J, Murphy OC, Saidha S
    Can Optical Coherence Tomography Be Used to Guide Treatment Decisions in Adult or Pediatric Multiple Sclerosis?
    Curr Treat Options Neurol. 2018;20:9.
    PubMed     Text format     Abstract available

  4. MISCHE LJ, Mowry EM
    The Evidence for Dietary Interventions and Nutritional Supplements as Treatment Options in Multiple Sclerosis: a Review.
    Curr Treat Options Neurol. 2018;20:8.
    PubMed     Text format     Abstract available


    J Neuroimmunol

  5. PAUNOVIC V, Petrovic IV, Milenkovic M, Janjetovic K, et al
    Autophagy-independent increase of ATG5 expression in T cells of multiple sclerosis patients.
    J Neuroimmunol. 2018 Mar 5. pii: S0165-5728(17)30538.
    PubMed     Text format     Abstract available


    J Neurol

  6. LANZILLO R, Prosperini L, Gasperini C, Moccia M, et al
    A multicentRE observational analysiS of PErsistenCe to Treatment in the new multiple sclerosis era: the RESPECT study.
    J Neurol. 2018 Mar 16. pii: 10.1007/s00415-018-8831.
    PubMed     Text format     Abstract available

  7. CERONIE B, Jacobs BM, Baker D, Dubuisson N, et al
    Cladribine treatment of multiple sclerosis is associated with depletion of memory B cells.
    J Neurol. 2018 Mar 17. pii: 10.1007/s00415-018-8830.
    PubMed     Text format     Abstract available

  8. NAKKEN O, Lindstrom JC, Holmoy T
    Sex ratio in multiple sclerosis mortality over 65 years; an age-period-cohort analysis in Norway.
    J Neurol. 2018 Mar 21. pii: 10.1007/s00415-018-8832.
    PubMed     Text format     Abstract available


    J Neurol Neurosurg Psychiatry

  9. POTTGEN J, Moss-Morris R, Wendebourg JM, Feddersen L, et al
    Randomised controlled trial of a self-guided online fatigue intervention in multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2018 Mar 16. pii: jnnp-2017-317463.
    PubMed     Text format     Abstract available


    Lancet

  10. THE LANCET
    End of the road for daclizumab in multiple sclerosis.
    Lancet. 2018;391:1000.
    PubMed     Text format    


    Lancet Neurol

  11. KAPOOR R, Ho PR, Campbell N, Chang I, et al
    Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension.
    Lancet Neurol. 2018 Mar 12. pii: S1474-4422(18)30069.
    PubMed     Text format     Abstract available

  12. EDAN G
    Natalizumab in secondary progressive multiple sclerosis.
    Lancet Neurol. 2018 Mar 12. pii: S1474-4422(18)30108.
    PubMed     Text format    


    Mult Scler

  13. HUA LH, Fan TH, Conway D, Thompson N, et al
    Discontinuation of disease-modifying therapy in patients with multiple sclerosis over age 60.
    Mult Scler. 2018 Mar 1:1352458518765656. doi: 10.1177/1352458518765656.
    PubMed     Text format     Abstract available


    Neurology

  14. ROTSTEIN DL, Chen H, Wilton AS, Kwong JC, et al
    Temporal trends in multiple sclerosis prevalence and incidence in a large population.
    Neurology. 2018 Mar 16. pii: WNL.0000000000005331.
    PubMed     Text format     Abstract available


    PLoS One

  15. BAGNATO F, Hametner S, Boyd E, Endmayr V, et al
    Untangling the R2* contrast in multiple sclerosis: A combined MRI-histology study at 7.0 Tesla.
    PLoS One. 2018;13:e0193839.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Multiple Sclerosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: